GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual GIP/GLP-1 agonist tirzepatide carry the clinical evidence: STEP for semaglutide ( The New England Journal of Medicine , 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM, 2024)
The trials included more than 3800 patients who were randomly assigned to semaglutide or placebo and followed for 2-years
In response to these challenges, increasing attention has been given to Chinese medicine as a potential alternative treatment for depression
300 In VSMCs, EZH2 restrains excessive autophagic death by suppressing ATG5 and ATG7 expression
For researchers exploring the broader landscape of peptides for fat loss , semaglutide is one option among several
Lipotropic injections focus on enhancing the bodys natural ability to burn fat